Srisuk T. PREVALENCE OF SGLT2 INHIBITOR AND GLP-1 RECEPTOR AGONIST PRESCRIPTIONS IN PATIENTS WITH COMORBID DIABETES AND CARDIOVASCULAR DISEASE IN RAJAVITHI HOSPITAL. J ASEAN Fed Endocr Soc [Internet]. 2023 Nov. 9 [cited 2024 Oct. 14];38(S3):56-7. Available from: https://asean-endocrinejournal.org/index.php/JAFES/article/view/3339